Overall, our results demonstrate that the low levels of tumor-infiltrating CD8+ Teff cells are dominated by CD4+ and CD8+ Tregs in CRC tumors, which display activated phenotypes with immunosuppressive functions [18]. The gene discussed is CD8A; the disease is neoplasm.